PuraPharm Corporation Limited (01498) released its monthly return for equity securities, covering the period ended 30 November 2025, and submitted on 4 December 2025. According to the announcement, the authorized share capital of 5,000,000,000,000 ordinary shares at a par value of USD 0.001 each remained unchanged, totaling USD 5,000,000,000.

The number of issued shares also stayed at 535,897,647 with zero treasury shares. The share option scheme, approved on 12 June 2015, had 23,962,424 outstanding share options at the end of November, with no new shares issued during the month. No warrants, convertibles, or other arrangements were listed, and no changes occurred in treasury shares or total issued shares during the period.